RISK FACTORS FOR EARLY POSTOPERATIVE COMPLICATIONS IN ACUTE ESFAGOGÁSTRICE ESPLENECTOMIA INFL COLITIS IN THE ERA OF BIOLOGIC THERAPY
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SOBRADO, Lucas Faraco | |
dc.contributor.author | MORI, Fernando Noboru Cabral | |
dc.contributor.author | FACANALI, Carolina Bortolozzo Graciolli | |
dc.contributor.author | CAMARGO, Mariane Gouvea Monteiro | |
dc.contributor.author | NAHAS, Sergio Carlos | |
dc.contributor.author | SOBRADO, Carlos Walter | |
dc.date.accessioned | 2023-12-15T18:51:47Z | |
dc.date.available | 2023-12-15T18:51:47Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Background: Despite major advances in the clinical treatment of inflammatory bowel disease, some patients still present with acute colitis and require emergency surgery. Aims: To evaluate the risk factors for early postoperative complications in patients undergoing surgery for acute colitis in the era of biologic therapy. Methods: Patients with inflammatory bowel disease admitted for acute colitis who underwent total colectomy at a single tertiary hospital from 2012 to 2022 were evaluated. Postoperative complications were graded according to Clavien-Dindo classification (CDC). Patients with more severe complications (CDC >= 2) were compared with those with less severe complications (CDC<2). Results: A total of 46 patients underwent surgery. The indications were: failure of clinical treatment (n=34), patients' or surgeon's preference (n=5), hemorrhage (n=3), toxic megacolon (n=2), and bowel perforation (n=2). There were eight reoperations, 60.9% of postoperative complications classified as CDC >= 2, and three deaths. In univariate analyses, preoperative antibiotics use, ulcerative colitis diagnosis, lower albumin levels at admission, and preoperative hospital stay longer than seven days were associated with more severe postoperative complications. Conclusions: Emergency surgery for acute colitis was associated with a high incidence of postoperative complications. Preoperative use of antibiotics, ulcerative colitis, lower albumin levels at admission, and delaying surgery for more than seven days were associated with more severe early postoperative complications. The use of biologics was not associated with worse outcomes. | eng |
dc.description.abstract | RACIONAL: Apesar dos enormes avanços no tratamento das doenças inflamatórias intestinais (DII), alguns pacientes apresentam quadros de colite aguda refratária ao tratamento clínico, e necessitam de cirurgia de urgência. OBJETIVOS: Avaliar os fatores de risco associados com complicações pós-operatórias precoces nos pacientes com colite aguda submetidos a colectomia na era das terapias biológicas. MÉTODOS: Pacientes com DII admitidos com colite aguda grave submetidos a colectomia total em hospital terciário no período de 2012 a 2022 foram analisados. As complicações pós-operatórias foram graduadas de acordo com a classificação Clavien-Dindo (CCD). Pacientes com complicações mais graves (CCD≥2) foram comparados com os menos graves (CCD<2). RESULTADOS: Foram submetidos a cirurgia 46 pacientes. As indicações foram: falha do tratamento conservador (n=34), preferência do paciente ou do cirurgião (n=5), hemorragia (n=3), megacólon tóxico (n=2) e perfuração intestinal (n=2). Reoperação foi necessária em oito pacientes, 60,9% tiveram complicações classificadas como CCD≥2, e três pacientes foram a óbito. Análise univariada identificou que uso de antibióticos no pré-operatório, diagnóstico de colite ulcerativa, hipoalbuminemia na admissão e período de internação maior que sete dias foi associada à complicações pós-operatória mais graves. CONCLUSÕES: Pacientes com colite aguda submetidos a cirurgia de urgência apresentaram alta taxa de complicações pós-operatórias. Uso pré-operatório de antibióticos, diagnóstico de retocolite ulcerativa, hipoalbuminemia na admissão e retardo na operação por mais que sete dias, esteve associado a complicações pós-operatórias mais graves. Uso de biológicos não se associou a piores desfechos. | |
dc.description.index | MEDLINE | |
dc.description.index | PubMed | |
dc.description.index | WoS | |
dc.description.index | Scopus | |
dc.identifier.citation | ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, v.36, article ID e1770, 6p, 2023 | |
dc.identifier.doi | 10.1590/0102-672020230052e1770 | |
dc.identifier.eissn | 2317-6326 | |
dc.identifier.issn | 0102-6720 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/57416 | |
dc.language.iso | eng | |
dc.publisher | COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD | eng |
dc.relation.ispartof | Abcd-Arquivos Brasileiros de Cirurgia Digestiva-brazilian Archives of Digestive Surgery | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD | eng |
dc.subject | Proctocolitis | eng |
dc.subject | Postoperative complications | eng |
dc.subject | Colitis | eng |
dc.subject | Colectomy | eng |
dc.subject | Risk factors | eng |
dc.subject | Biological therapy | eng |
dc.subject | Proctocolite | |
dc.subject | Complicações pós-operatórias | |
dc.subject | Colite | |
dc.subject | Colectomia | |
dc.subject | Fatores de risco | |
dc.subject | Terapia biológica | |
dc.subject.other | severe ulcerative-colitis | eng |
dc.subject.other | rescue therapy | eng |
dc.subject.other | colectomy | eng |
dc.subject.other | infliximab | eng |
dc.subject.other | management | eng |
dc.subject.other | outcomes | eng |
dc.subject.wos | Gastroenterology & Hepatology | eng |
dc.title | RISK FACTORS FOR EARLY POSTOPERATIVE COMPLICATIONS IN ACUTE ESFAGOGÁSTRICE ESPLENECTOMIA INFL COLITIS IN THE ERA OF BIOLOGIC THERAPY | eng |
dc.title.alternative | FATORES DE RISCO PARA COMPLICAÇÕES PÓS-OPERATÓRIAS PRECOCES EM COLITE AGUDA NA ERA DA TERAPIA BIOLÓGICA | |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 1 | |
hcfmusp.contributor.author-fmusphc | LUCAS FARACO SOBRADO | |
hcfmusp.contributor.author-fmusphc | FERNANDO NOBORU CABRAL MORI | |
hcfmusp.contributor.author-fmusphc | CAROLINA BORTOLOZZO GRACIOLLI FACANALI | |
hcfmusp.contributor.author-fmusphc | MARIANE GOUVEA MONTEIRO DE CAMARGO | |
hcfmusp.contributor.author-fmusphc | SERGIO CARLOS NAHAS | |
hcfmusp.contributor.author-fmusphc | CARLOS WALTER SOBRADO JUNIOR | |
hcfmusp.description.articlenumber | e1770 | |
hcfmusp.description.volume | 36 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 37878974 | |
hcfmusp.origem.scopus | 2-s2.0-85175219873 | |
hcfmusp.origem.wos | WOS:001091690800001 | |
hcfmusp.publisher.city | SAO PAULO SP | eng |
hcfmusp.publisher.country | BRAZIL | eng |
hcfmusp.relation.reference | Actis GC, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-13 | eng |
hcfmusp.relation.reference | Aratari A, 2008, DIGEST LIVER DIS, V40, P821, DOI 10.1016/j.dld.2008.03.014 | eng |
hcfmusp.relation.reference | Bartels SAL, 2013, COLORECTAL DIS, V15, P1392, DOI 10.1111/codi.12328 | eng |
hcfmusp.relation.reference | Biondi A, 2012, WORLD J GASTROENTERO, V18, P1861, DOI 10.3748/wjg.v18.i16.1861 | eng |
hcfmusp.relation.reference | CHAPMAN RW, 1986, GUT, V27, P1210, DOI 10.1136/gut.27.10.1210 | eng |
hcfmusp.relation.reference | Coakley BA, 2013, SURGERY, V153, P242, DOI 10.1016/j.surg.2012.08.002 | eng |
hcfmusp.relation.reference | de Silva S, 2011, CLIN GASTROENTEROL H, V9, P972, DOI 10.1016/j.cgh.2011.07.016 | eng |
hcfmusp.relation.reference | Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae | eng |
hcfmusp.relation.reference | Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009 | eng |
hcfmusp.relation.reference | Holubar SD, 2021, DIS COLON RECTUM, V64, P783, DOI 10.1097/DCR.0000000000002037 | eng |
hcfmusp.relation.reference | HURST RD, 1995, SURGERY, V118, P748, DOI 10.1016/S0039-6060(05)80045-5 | eng |
hcfmusp.relation.reference | Järnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003 | eng |
hcfmusp.relation.reference | Khoudari G, 2022, CLIN GASTROENTEROL H, V20, pE974, DOI 10.1016/j.cgh.2020.10.008 | eng |
hcfmusp.relation.reference | Kokkinidis DG, 2017, SCAND J GASTROENTERO, V52, P923, DOI 10.1080/00365521.2017.1326163 | eng |
hcfmusp.relation.reference | Leeds IL, 2017, J GASTROINTEST SURG, V21, P1675, DOI 10.1007/s11605-017-3538-3 | eng |
hcfmusp.relation.reference | Li Y, 2015, J GASTROINTEST SURG, V19, P1842, DOI 10.1007/s11605-015-2893-1 | eng |
hcfmusp.relation.reference | Mendonça CM, 2022, ABCD-ARQ BRAS CIR DI, V35, DOI 10.1590/0102-672020210002e1653 | eng |
hcfmusp.relation.reference | Narula N, 2015, INFLAMM BOWEL DIS, V21, P1683, DOI 10.1097/MIB.0000000000000350 | eng |
hcfmusp.relation.reference | Nelson R, 2014, INFLAMM BOWEL DIS, V20, P14, DOI 10.1097/01.MIB.0000437497.07181.05 | eng |
hcfmusp.relation.reference | Powar MP, 2013, COLORECTAL DIS, V15, P374, DOI 10.1111/j.1463-1318.2012.03188.x | eng |
hcfmusp.relation.reference | Randall J, 2010, BRIT J SURG, V97, P404, DOI 10.1002/bjs.6874 | eng |
hcfmusp.relation.reference | Ribiere S, 2018, PRESSE MED, V47, P312, DOI 10.1016/j.lpm.2018.02.020 | eng |
hcfmusp.relation.reference | Saha SK, 2018, INT J COLORECTAL DIS, V33, P79, DOI 10.1007/s00384-017-2903-8 | eng |
hcfmusp.relation.reference | Sobrado CW, 2016, ABCD-ARQ BRAS CIR DI, V29, P201, DOI 10.1590/0102-6720201600030017 | eng |
hcfmusp.relation.reference | Tajra JBM, 2023, ABCD-ARQ BRAS CIR DI, V36, DOI 10.1590/0102-672020230002e1730 | eng |
hcfmusp.relation.reference | TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041 | eng |
hcfmusp.relation.reference | Xu YY, 2019, INFLAMM BOWEL DIS, V25, P261, DOI 10.1093/ibd/izy246 | eng |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | 299c36c2-1118-4151-8a46-7a9b09fa7ca3 | |
relation.isAuthorOfPublication | fbd77eed-33d2-4c59-a871-e6e47d1078a4 | |
relation.isAuthorOfPublication | 9804c3ec-7554-481f-9eca-73afdaec27a0 | |
relation.isAuthorOfPublication | 072fb633-a9b0-4a37-886e-8e3620686d5b | |
relation.isAuthorOfPublication | 0ab50572-97be-4931-8ade-d2f681c8b19e | |
relation.isAuthorOfPublication | 9a1bbab0-4ee3-43da-b488-6a88fbf0e76a | |
relation.isAuthorOfPublication.latestForDiscovery | 299c36c2-1118-4151-8a46-7a9b09fa7ca3 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_SOBRADO_RISK_FACTORS_FOR_EARLY_POSTOPERATIVE_COMPLICATIONS_IN_ACUTE_2023.PDF
- Tamanho:
- 550.37 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)